Aysen Unsal is a Commercialisation Officer at Imperial College London, supporting and leading on the commercialisation of MedTech and HealthTech related inventions from Imperial’s Faculty of Engineering. Aysen has a background in Biomedical Science and Medical Device Entrepreneurship.
Aysen's portfolio
Cellular therapy for glaucoma
A cellular therapy to locally deliver nitric oxide (NO) to the conventional aqueous humour outflow pathway, thereby lowering eye pressure and preserving vision in glaucoma. Find out more
An Inducible, multiplexed CRISPR system
A CRISPR-based platform for inducibly up- and down-regulating up to 24 genes in the yeast, Saccharomyces cerevisiae. Find out more
Intelligent handheld surgery: precision microsurgical tools and realtime tissue mapping
Neurosurgical clip and actuator with stability and freedom of movement; non-invasive tumour identification probe for real-time mapping Find out more
Small-molecule inducible promoters for tuned gene expression in Yarrowia lipolytica
A method for fine-tuning gene expression in Yarrowia Lipoltica Find out more
A cytokine for wound healing and scar reduction
A cytokine that promotes wound healing by accelerating re-epithelialization of the wound bed faster than FDA approved products. The treatment also has a potential to minimise scarring after injury. Find out more
Bioharmonophores for biomedical precision imaging
Biodegradable, second-harmonic generating nanoprobes for targeted, high-resolution in vivo tumour imaging Find out more
Sign up for updates
Sign up for monthly technology alerts via email, and find other ways to connect with us.